Organigram Q3 Sales Grow to $3.7 Million | CashCropToday
0 Shares 470 Views

Organigram Q3 Sales Grow to $3.7 Million

July 31, 2018
470 Views

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF), a medical cannabis cultivation and distribution company out of New Brunswick, Canada has announced its Q3 sales for 2018. Within the three month period the company was able to produce $3.7 million dollars in sales. This total surpasses what Organigram was capable of selling in the entire fiscal year of 2017.

Organigram has made a number of strategic moves during this period. In May, Organigram received its “License for Controlled Drugs and Substances” from Health Canada and its “Permit to Export Cannabis” license. This lead to the company’s first international export of medicinal cannabis to Australia in July.

Within the third quarter the company recorded the sale of 303,428 grams of dried cannabis flower, 768,400 milliliters of cannabis oil, and had accomplished rising its registered medical patient list to a company best of 15,316.

Organigram’s assets at the end of Q3 is as follows:

  • $156 million in cash and short-term investments (up from $34 million at the August 31, 2017 year-end);
  • $26.9 million in combined biological assets and inventories (up from $5.4 million at year-end);
  • $83 million in property, plant and equipment (up from $45 million at year-end);
  • $9 million in current liabilities (up from $6 million at year-end);
  • $98 million in long-term debt and convertible debentures (up from $3 million at year-end)

You may be interested

Featured CCT Interview with CEO of Eden Labs AC Braddock
Manufacturing
21 views
Manufacturing
21 views

Featured CCT Interview with CEO of Eden Labs AC Braddock

Editor - August 20, 2018

Eden Labs LLC. has been developing and providing plant based extraction equipment out of Seattle, Washington for some of the largest and most respected companies involved in…

VividGro, a Pegasus Capital Advisors Portfolio Company,  Announces Partnership with Merida Capital Partners
Market Watch
242 views
Market Watch
242 views

VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital Partners

Editor - August 17, 2018

Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million
Market Watch
334 views
Market Watch
334 views

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million

Editor - August 15, 2018

Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: